Conference | ESMO

Sara Astarita and Michiel Stevens represented Tzu Cancer Therapeutics at the annual conference of the European Society of Medical Oncologist.

Besides seeing the great progress that is being made with the clinical adoption of various forms of targeted therapies, the meeting provided a valuable opportunity to (re-)connect with leading oncologist, researchers and therapy developers.

The increasing utilization of targeted therapeutics across cancer types further strengthens our dedication to provide researchers, oncologists and pharma developers with the most important information: What does the active, metastasizing part of the cancer look like in each individual patient.